Search Count: 14
![]() |
Naturally Occurring Mutations In The Mps1 Gene Predispose Cells To Kinase Inhibitor Drug Resistance.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2015-09-23 Classification: TRANSFERASE Ligands: AU5, P4C, DMS, EDO |
![]() |
Naturally Occurring Mutations In The Mps1 Gene Predispose Cells To Kinase Inhibitor Drug Resistance.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2015-09-23 Classification: TRANSFERASE Ligands: O38, GOL, MG |
![]() |
Naturally Occurring Mutations In The Mps1 Gene Predispose Cells To Kinase Inhibitor Drug Resistance.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2015-09-23 Classification: TRANSFERASE Ligands: PWU |
![]() |
Naturally Occurring Mutations In The Mps1 Gene Predispose Cells To Kinase Inhibitor Drug Resistance.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2015-09-23 Classification: TRANSFERASE Ligands: 7PE, AU5, DMS, EDO |
![]() |
Naturally Occurring Mutations In The Mps1 Gene Predispose Cells To Kinase Inhibitor Drug Resistance.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.85 Å Release Date: 2015-09-23 Classification: TRANSFERASE Ligands: O38, 7PE, EDO |
![]() |
Naturally Occurring Mutations In The Mps1 Gene Predispose Cells To Kinase Inhibitor Drug Resistance.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2015-09-23 Classification: TRANSFERASE Ligands: 7RO, 1KA, PGE, EDO |
![]() |
Naturally Occurring Mutations In The Mps1 Gene Predispose Cells To Kinase Inhibitor Drug Resistance.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2015-09-23 Classification: TRANSFERASE Ligands: PWU, EDO, DMS |
![]() |
Naturally Occurring Mutations In The Mps1 Gene Predispose Cells To Kinase Inhibitor Drug Resistance.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2015-09-23 Classification: TRANSFERASE Ligands: SVE, EDO, DMS |
![]() |
Structure-Based Design Of Orally Bioavailable Pyrrolopyridine Inhibitors Of The Mitotic Kinase Mps1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2013-12-04 Classification: TRANSFERASE Ligands: 4T9, 1PE, 7PE |
![]() |
Structure-Based Design Of Orally Bioavailable Pyrrolopyridine Inhibitors Of The Mitotic Kinase Mps1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.36 Å Release Date: 2013-12-04 Classification: TRANSFERASE Ligands: 7PE, 7CE, EDO |
![]() |
Structure-Based Design Of Orally Bioavailable Pyrrolopyridine Inhibitors Of The Mitotic Kinase Mps1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2013-12-04 Classification: TRANSFERASE Ligands: 7RO, 7PE, EDO |
![]() |
Structure-Based Design Of Orally Bioavailable Pyrrolopyridine Inhibitors Of The Mitotic Kinase Mps1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2013-12-04 Classification: TRANSFERASE Ligands: 7RO, 7PE |
![]() |
Structure-Based Design Of Orally Bioavailable Pyrrolopyridine Inhibitors Of The Mitotic Kinase Mps1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2013-12-04 Classification: TRANSFERASE Ligands: X20, 7PE |
![]() |
Structure-Based Design Of Orally Bioavailable Pyrrolopyridine Inhibitors Of The Mitotic Kinase Mps1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2013-12-04 Classification: TRANSFERASE Ligands: X21 |